QIAGEN N.V. (QGEN) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2025-12-31..
Quick ratio
Overview →Financial period ending 2025-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2025-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 512.14M USD | Liabilities, Current |
| Cash and equivalents | 839.00M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 402.61M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 301.89M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | (m) | $512.14M | $839.00M | (m) | $402.61M | $301.89M | (m) |
| 2024-12-31 | (m) | $543.63M | $663.55M | (m) | $349.28M | $279.26M | (m) |
| 2023-12-31 | (m) | $1.08B | $668.08M | (m) | $381.88M | $398.38M | (m) |
| 2022-12-31 | (m) | $974.52M | $730.67M | (m) | $323.75M | $357.96M | (m) |
| 2021-12-31 | (m) | $1.52B | $880.52M | (m) | $362.13M | $327.52M | (m) |
| 2020-12-31 | (m) | $615.09M | $597.98M | (m) | $380.52M | $291.18M | (m) |
| 2019-12-31 | (m) | $951.35M | $623.65M | (m) | $385.12M | $170.70M | (m) |
| 2018-12-31 | (m) | $972.19M | $1.16B | (m) | $351.61M | $162.91M | (m) |
| 2018-01-01 | (m) | (m) | (m) | (m) | $329.30M | (m) | (m) |
| 2017-12-31 | (m) | $324.79M | $657.71M | (m) | $329.14M | $155.93M | (m) |
| 2016-12-31 | (m) | $308.43M | $439.18M | (m) | $278.24M | $136.55M | (m) |
| 2015-12-31 | (m) | $268.35M | $290.01M | (m) | $273.85M | $136.59M | (m) |
| 2014-12-31 | (m) | $431.63M | $392.67M | (m) | $265.23M | $132.28M | (m) |
| 2013-12-31 | (m) | $337.04M | $330.30M | (m) | $259.71M | $128.10M | (m) |
| 2012-12-31 | (m) | $266.87M | $394.04M | (m) | $250.73M | $135.29M | (m) |
| 2011-12-31 | (m) | $481.66M | $221.13M | (m) | $230.77M | $132.24M | (m) |
| 2010-12-31 | (m) | $388.41M | $828.41M | (m) | $197.42M | $126.63M | (m) |
| 2009-12-31 | (m) | $375.53M | $825.56M | (m) | $193.74M | $130.85M | (m) |
| 2008-12-31 | (m) | (m) | $333.31M | (m) | (m) | (m) | (m) |
| 2007-12-31 | (m) | (m) | $347.32M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.